Wed, December 11, 2024
[ Wed, Dec 11th 2024 ]: Investopedia
Top Stock Movers Now: Google Parent Alphabet, Netflix, Tesla, and More
[ Wed, Dec 11th 2024 ]: The Australian Financial Review
How to pick the ASX's next dividend winners
[ Wed, Dec 11th 2024 ]: Business Insider
Oppenheimer sets Wall Street's highest S&P 500 pr .. e target as it eyes 17% upside for stocks in 2025
[ Wed, Dec 11th 2024 ]: Forbes
6 Best Value Stocks To Buy In 2025
[ Wed, Dec 11th 2024 ]: Kiplinger
Stock Market Today: Tech Stocks Rally as CPI Supports Lower Rates
[ Wed, Dec 11th 2024 ]: USA Today
Intel's stock did something it hasn't done since 2022
[ Wed, Dec 11th 2024 ]: The Globe and Mail
Market Factors: The most interesting lookahead to 2025 that I've seen
[ Wed, Dec 11th 2024 ]: Seeking Alpha
CVS: Why I'm Selling My Worst Holding Of 2024
[ Wed, Dec 11th 2024 ]: CBS News
Inflation is rising again: Why you should invest in gold now
[ Wed, Dec 11th 2024 ]: U.S. News & World Report
7 Growth Stocks That Also Pay Dividends
[ Wed, Dec 11th 2024 ]: The Motley Fool Canada
3 Top Small-Cap Stocks to Buy for Next 3 Years
[ Wed, Dec 11th 2024 ]: U.S. News & World Report
NYSE's Lynn Martin Sees Active IPO Market in 2025
[ Wed, Dec 11th 2024 ]: The Motley Fool UK
2 FTSE 100 shares I plan to avoid like the plague in 2025
[ Wed, Dec 11th 2024 ]: U.S. News & World Report
8 Best Quantum Computing Stocks to Buy for 2025
[ Wed, Dec 11th 2024 ]: Seeking Alpha
Cash COWs And Buried Treasures: 2024 Performance Review
[ Wed, Dec 11th 2024 ]: The Motley Fool Canada
1 Canadian Utility Stock to Buy for Big Total Returns
[ Wed, Dec 11th 2024 ]: Insider Monkey
Why Archer Aviation (ACHR) Is the Worst ARK Stock to Buy According to Short Sellers?
[ Wed, Dec 11th 2024 ]: The Globe and Mail
The latest Bank of Canada rate cut will drive these five personal finance trends in 2025
[ Wed, Dec 11th 2024 ]: Insider Monkey
Is NVIDIA Corporation (NVDA) Among the Best Aggre .. ve Growth Stocks to Buy According to Hedge Funds?
[ Wed, Dec 11th 2024 ]: ig.com
AUD/USD, EUR/GBP drop to multi-year lows while EUR/USD dips
[ Wed, Dec 11th 2024 ]: Morningstar
The Best and Worst New ETFs of 2024
[ Wed, Dec 11th 2024 ]: Which
Investing in cryptocurrency: the most common misconceptions and mistakes
[ Wed, Dec 11th 2024 ]: Naija Gist - Latest
How to build a diversified portfolio as a Nigerian online trader
[ Wed, Dec 11th 2024 ]: Seeking Alpha
EIC Vs. HYG: One Fund Is A Better High Yield Investment
[ Wed, Dec 11th 2024 ]: The Motley Fool Canada
2 High-Yield Dividend ETFs to Buy to Generate Passive Income
[ Wed, Dec 11th 2024 ]: MarketWatch
These 10 most-loved S&P 500 stocks could see as much as 50% upside in 2025
[ Wed, Dec 11th 2024 ]: Business Line
bl interview. AI can help India leapfrog and clos .. with large economies, says Blackrock's Ben Powell
[ Wed, Dec 11th 2024 ]: The Globe and Mail
Better Buy for 2025: Bitcoin vs. Nvidia?
[ Wed, Dec 11th 2024 ]: 24/7 Wall St
3 S&P 500 Growth Stocks Everyone Should Own
[ Wed, Dec 11th 2024 ]: Seeking Alpha
My Top 2 Stock Picks For A 2025 Rebound
[ Wed, Dec 11th 2024 ]: The Motley Fool
3 Vanguard ETFs That Can Help Build Your Perfect Portfolio
[ Wed, Dec 11th 2024 ]: The Motley Fool
Should You Forget Nvidia and Buy This AI Stock Sp .. it Giant That's Soared More than 400% in 5 Years?
[ Wed, Dec 11th 2024 ]: MoneyWeek
Investing for children this Christmas - five ideas
[ Wed, Dec 11th 2024 ]: marketindex
How much, and when the RBA will cut interest rates in 2025
[ Wed, Dec 11th 2024 ]: Yahoo Finance
Is Exxon Mobil Corporation (XOM) the Best American Dividend Stock to Buy Right Now?
[ Wed, Dec 11th 2024 ]: DSIJ Pvt Ltd
Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis
[ Wed, Dec 11th 2024 ]: The Motley Fool
3 Breakout Stocks for 2025
[ Wed, Dec 11th 2024 ]: MSN
Bitcoin Hit an All-Time High Above $100,000. Is It a Buy?
[ Wed, Dec 11th 2024 ]: Yahoo Finance
Wall Street's Most Prominent Reverse Stock Split .. ne of Warren Buffett's Top Stocks to Buy for 2025
[ Wed, Dec 11th 2024 ]: MSN
Why The PNC Financial Services Group (PNC) Is the Best Bank Stock to Invest in for the Long Term?
[ Wed, Dec 11th 2024 ]: Insider Monkey
Why Bank of America Corporation (BAC) Is the Best Bank Stock to Invest in for the Long Term?
[ Wed, Dec 11th 2024 ]: Insider Monkey
Is Citizens Financial Group (CFG) the Best Bank Stock to Invest in for the Long Term?
[ Wed, Dec 11th 2024 ]: The Motley Fool UK
Google unveils new quantum chip! This FTSE 100 stock offers a cheap way for me to invest
[ Wed, Dec 11th 2024 ]: MSN
Vijay Kedia multibagger stocks: Returns up to 4200% in 5 years - LIST
[ Wed, Dec 11th 2024 ]: The Motley Fool
Is D-Wave Quantum Stock a Buy?
[ Wed, Dec 11th 2024 ]: MSN
Why Silex Systems, SCEE, Titomic, and WA1 shares are storming higher today
[ Wed, Dec 11th 2024 ]: The Globe and Mail
Stocks cheered Trump's victory, but tariffs bring unknowns to 2025
[ Wed, Dec 11th 2024 ]: CNN-News18
How Rs 10,000 Monthly SIP Grew To Rs 13 Crore In 31 Years For This Investor

Jim Cramer Says He Would Prefer Eli Lilly (LLY) Over Regeneron Even at $900

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. er-eli-lilly-lly-over-regeneron-even-at-900.html
  Print publication without navigation Published in Stocks and Investing on by Insider Monkey
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
We recently published a list of Jim Cramer's Latest Calls: Top 10 Stocks. In this article, we are going to take a look at where Eli Lilly And Co (NYSE:LLY) stands against other stocks highlighted in Jim Cramer's latest calls.
Jim Cramer, a prominent financial commentator, has expressed a strong preference for Eli Lilly (LLY) over Regeneron Pharmaceuticals, even if Eli Lilly's stock price were to reach $900 per share. In his analysis, Cramer highlights Eli Lilly's robust pipeline and its potential in the obesity and diabetes markets, particularly with drugs like Mounjaro, which has shown promising results. He contrasts this with Regeneron, noting that while it has successful products like Eylea for eye diseases, its future growth might not match Eli Lilly's due to less diversified and less expansive upcoming treatments. Cramer's endorsement of Eli Lilly is based on its innovation, market positioning, and the significant impact its new drugs could have on its revenue and stock performance.

Read the Full Insider Monkey Article at:
[ https://www.insidermonkey.com/blog/jim-cramer-says-he-would-prefer-eli-lilly-lly-over-regeneron-even-at-900-1405891/ ]